AI English summary of an SEC filing — figures as filed
Boston Scientific BSXThe company said its board approved the 2025 Annual Bonus Plan on November 19, 2024, January 1, 2025, based on the recommendation of the Compensation Committee, for the performance year running from December 31. It said the plan is substantially similar to the 2024 annual bonus plan.
Key points
AI summaryThe company said its board approved the 2025 Annual Bonus Plan on November 19, 2024, January 1, 2025, based on the recommendation of the Compensation Committee, for the performance year running from December 31. It said the plan is substantially similar to the 2024 annual bonus plan.
The company said the Compensation Committee will set the distribution percentage of the target bonus pool within a range of 0% to 150%, and managers will assign individual performance modifiers of 0% to 150%, resulting in a maximum individual payout of 0% to 225% of target bonus.
The company said on November 19, 2024 its board approved the 2025 Relative Total Shareholder Return and 2025 Organic Net Sales Growth performance share programs. The performance period for both programs runs from January 1, 2025 to December 31, 2027, a period of 3 years, and the number of shares paid will be 0% to 200% of each participant's target number of awards.
The company said awards to certain executive officers under the 2025 annual bonus plan and both performance share programs are subject to its discretionary recoupment policy, the Dodd-Frank Clawback Policy and other compensation recovery policies adopted by the board.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Approval of 2025 Annual Bonus Plan
The company said its board approved the 2025 Annual Bonus Plan on November 19, 2024, January 1, 2025, based on the recommendation of the Compensation Committee, for the performance year running from December 31. It said the plan is substantially similar to the 2024 annual bonus plan.
Source · Based on the filing body and exhibits
Annual Bonus Payout Percentage and Individual Maximum Payout Limit
The company said the Compensation Committee will set the distribution percentage of the target bonus pool within a range of 0% to 150%, and managers will assign individual performance modifiers of 0% to 150%, resulting in a maximum individual payout of 0% to 225% of target bonus.
Source · Based on the filing body and exhibits
Approval of 2025 rTSR PSP and Organic Net Sales PSP
The company said on November 19, 2024 its board approved the 2025 Relative Total Shareholder Return and 2025 Organic Net Sales Growth performance share programs. The performance period for both programs runs from January 1, 2025 to December 31, 2027, a period of 3 years, and the number of shares paid will be 0% to 200% of each participant's target number of awards.
Source · Based on the filing body and exhibits
Application of Bonus and Performance Share Clawback Policies
The company said awards to certain executive officers under the 2025 annual bonus plan and both performance share programs are subject to its discretionary recoupment policy, the Dodd-Frank Clawback Policy and other compensation recovery policies adopted by the board.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…